CWBR CohBar
- 0.490
- -0.023-4.48%
CohBar News
Liver Disease Drug Developers Rise After Gilead-CymaBay M&A Deal
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
CohBar Announces Nasdaq's Notice of Delisting; Does Not Plan to Request Hearing
CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K)
U.S. Shares Higher at Close of Trade; Dow Jones Industrial Average up 0.67%
Why CohBar (CWBR) Stock Is Down Nearly 50% Today
SLN, EKSO and BANL Among Mid-day Movers
12 Health Care Stocks Moving In Wednesday's Intraday Session
G1 Therapeutics, BioXcel Therapeutics Among Healthcare Movers
CohBar Shares Slide to New Depths on Plans to Liquidate
CohBar Says It Intends To Commence Process Of Liquidating And Dissolving Itself In Accordance With Its Organizational Documents And Applicable Law
CohBar Says On Nov 1, Got Termination Notice From Morphogenesis, Effective Nov 1 And Merger Agreement Was Terminated In Accordance With Terms
CohBar Says On Oct 31, Board Determined There Was Not Viable Path Forward To Consummate Merger Primarily Due To Oral Guidance Received From Nasdaq
Akero Plummets After Mid-stage Data for NASH Candidate
12 Health Care Stocks Moving In Monday's After-Market Session
CohBar GAAP EPS of -$1.49
CohBar | 8-K: CohBar Reports Second Quarter 2023 Financial Results
Cohbar 2Q Loss/Shr $1.49 >CWBR
Press Release: CohBar Reports Second Quarter 2023 Financial Results
Analysis
Price Target
No Data
No Data